Medi-Caps

₹51.9 1.4 | 2.8%

WEBSITE BSE:523144 NSE : MEDI CAPS 18 May, 12:50

Market Cap ₹65 Cr.

Stock P/E -81.0

P/B 0.5

Current Price ₹51.9

Book Value ₹ 96

Face Value 10

52W High ₹63.5

Dividend Yield 0%

52W Low ₹ 36

Edit Ratio

Medi-Caps Research see more...

Overview Inc. Year: 1983Industry: Chemicals

Medi-Caps Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Medi-Caps Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	17	18	18	12	15	11	11	6	6	7
Other Income	0	0	1	0	1	0	0	0	0	0
Total Income	17	18	19	13	16	11	11	6	6	7
Total Expenditure	14	15	17	12	14	9	10	7	6	6
Operating Profit	4	3	2	1	3	2	1	-1	1	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	1	1	1	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	3	2	1	1	2	1	1	-1	0	0
Provision for Tax	0	0	0	0	0	3	0	0	0	1
Profit After Tax	3	2	1	1	2	-1	0	-1	0	-0
Adjustments	-0	-0	0	-0	-0	-0	-0	-0	0	0
Profit After Adjustments	3	2	1	1	2	-1	0	-1	0	-0
Adjusted Earnings Per Share	2.6	1.6	1.2	0.5	1.7	-1.1	0.3	-0.9	0.1	-0.1

Medi-Caps Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	30	37	36	43	44	50	52	43	59	70	49	30
Other Income	1	1	1	1	2	1	3	3	1	2	2	0
Total Income	31	39	37	44	46	51	55	46	59	72	51	30
Total Expenditure	28	36	36	40	42	48	47	50	46	60	44	29
Operating Profit	2	3	1	3	4	3	7	-4	13	12	7	2
Interest	1	1	1	0	0	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	2	2	2	2	2	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-0	-1	-1	1	2	1	6	-6	11	10	5	0
Provision for Tax	1	1	1	1	0	0	0	0	-0	0	3	1
Profit After Tax	-1	-2	-2	1	1	1	5	-6	11	10	2	-1
Adjustments	1	0	0	0	0	0	0	0	-0	0	-0	0
Profit After Adjustments	-1	-1	-2	1	1	1	5	-6	11	10	2	-1
Adjusted Earnings Per Share	-0.6	-1	-1.7	0.7	1.1	0.9	4.3	-4.7	8.9	8.1	1.4	-0.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-30%	4%	-0%	5%
Operating Profit CAGR	-42%	0%	18%	13%
PAT CAGR	-80%	0%	15%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	27%	7%	29%	19%
ROE Average	2%	7%	4%	2%
ROCE Average	4%	8%	5%	3%

Medi-Caps Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	88	83	81	82	89	90	96	91	105	116	119
Minority's Interest	3	3	0	0	0	0	0	0	0	0	0
Borrowings	6	9	1	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1	1	1	1	1	2	2	1	1	1	2
Total Current Liabilities	5	6	6	9	7	9	9	3	9	13	5
Total Liabilities	102	102	89	93	97	101	107	95	115	130	126
Fixed Assets	39	37	58	56	61	60	59	57	58	59	59
Other Non-Current Assets	33	28	4	5	3	4	6	5	4	4	7
Total Current Assets	31	37	27	32	33	37	42	33	53	67	60
Total Assets	102	102	89	93	97	101	107	95	115	130	126

Medi-Caps Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	2	1	1	1	1	2	2	2	1	7	10
Cash Flow from Operating Activities	-14	-1	7	3	4	4	6	5	15	7	-6
Cash Flow from Investing Activities	6	2	-7	-1	3	-4	-6	-6	-10	-4	-3
Cash Flow from Financing Activities	7	-0	0	-1	-6	0	-0	-0	-0	0	0
Net Cash Inflow / Outflow	-1	0	0	0	1	0	0	-1	6	3	-9
Closing Cash & Cash Equivalent	1	1	1	1	2	2	2	1	7	10	1

Medi-Caps Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0.57	-1.04	-1.65	0.69	1.1	0.92	4.32	-4.69	8.92	8.08	1.41
CEPS(Rs)	0.56	0.23	-0.2	2.14	2.55	2.36	5.78	-3.23	10.24	9.51	2.89
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	62.98	66.93	65.28	65.98	71.44	72.35	76.67	72.94	83.97	93.23	95.09
Core EBITDA Margin(%)	4.95	3.57	-0.24	5.71	3.43	3.99	8.52	-15.02	20.91	14.4	10.51
EBIT Margin(%)	0.75	1.14	-1.54	3.25	3.9	2.67	10.16	-12.71	19.32	14.55	10.23
Pre Tax Margin(%)	-0.8	-1.74	-3.23	3.12	3.7	2.49	9.93	-12.97	19.14	14.39	9.97
PAT Margin (%)	-4.31	-4.43	-5.28	1.89	2.94	2.12	9.72	-12.99	19.15	14.37	3.78
Cash Profit Margin (%)	2.15	0.72	-0.65	5.84	6.82	5.43	13	-8.93	21.74	16.97	7.31
ROA(%)	-1.41	-1.74	-2.15	0.95	1.44	1.16	5.19	-5.8	10.71	8.19	1.46
ROE(%)	-1.78	-2.2	-2.5	1.06	1.6	1.28	5.8	-6.27	11.49	9.09	1.59
ROCE(%)	0.27	0.49	-0.69	1.8	2.12	1.61	6.06	-6.13	11.59	9.2	4.3
Receivable days	76.74	90.7	94.24	73.36	73.09	74.02	85.21	69.91	33.54	42.99	68.52
Inventory Days	63.69	87.11	113.38	113.61	110.47	78.76	69.44	66.36	37.77	48.47	69.93
Payable days	56.77	45.79	61.37	82.81	89.5	77.16	94.76	62.63	56.73	117.84	124.89
PER(x)	0	0	0	29.52	25.16	25.05	3.83	0	4.52	6.14	24.81
Price/Book(x)	0.22	0.16	0.21	0.31	0.39	0.32	0.22	0.11	0.48	0.53	0.37
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0.76	0.56	0.48	0.57	0.74	0.54	0.35	0.21	0.74	0.75	0.86
EV/Core EBITDA(x)	9.69	8.36	14.38	7.39	8.93	8.21	2.45	-2.31	3.38	4.35	6.25
Net Sales Growth(%)	15.56	24.89	-3.68	19	2.48	12.8	4.24	-16.86	36.39	18.99	-29.34
EBIT Growth(%)	-90.32	86.5	-231.46	347.12	22.41	-20.3	289.13	-201.63	298.08	-10.37	-50.34
PAT Growth(%)	-254.24	-26.19	-15.53	141.94	58.36	-16.11	369.44	-208.63	292.16	-10.69	-81.42
EPS Growth(%)	-146.75	-81.8	-58.84	141.94	58.36	-16.11	369.46	-208.63	290.18	-9.42	-82.58
Debt/Equity(x)	0.08	0.11	0.01	0	0	0	0	0	0	0	0
Current Ratio(x)	6.58	6.3	4.52	3.35	4.89	4.14	4.59	9.82	5.68	5.05	11.65
Quick Ratio(x)	4.78	4.46	2.24	1.77	2.94	3.01	3.4	8.2	4.96	4.15	10.28
Interest Cover(x)	0.48	0.39	-0.91	24.49	19	14.43	42.94	-48.87	110.44	93.95	39.47
Total Debt/Mcap(x)	0.36	0.68	0.05	0	0	0.01	0.01	0.01	0	0	0

Medi-Caps Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.13
FII	0	0	0	0	0	0	0	0	0	0
DII	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Public	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.84
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.62	0.62	0.62	0.62	0.62	0.62	0.62	0.62	0.62	0.62
Others	0	0	0	0	0	0	0	0	0	0
Total	1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.25

Pros

Stock is trading at 0.5 times its book value
Company is almost debt free.

Cons

Company has a low return on equity of 7% over the last 3 years.
Debtor days have increased from 117.84 to 124.89days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.